Results 11 to 20 of about 3,593,458 (250)

Synchronous Bilateral Male Breast Cancer: A Rare Case Report

Haseki Tıp Bülteni, 2019
Male breast cancer accounts for less than 1% of all breast carcinomas and 0.17 to -1.5% of all cancers seen in men. The incidence of synchronous bilateral male breast cancer has been reported to be 1.5%-2% of all male breast cancers.
Muzaffer Akıncı, Zehra Keklikkıran, Mürşit Dinçer   +2 more
doaj   +2 more sources

Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in Cypriot population. [PDF]

, 2010
Inability to correctly repair DNA damage is known to play a role in the development of breast cancer. Single nucleotide polymorphisms (SNPs) of DNA repair genes have been identified, which modify the DNA repair capacity, which in turn may affect the risk
Daniel, M, Hadjisavvas, A, Loizidou, MA, Newbold, RF, Neuhausen, SL, Marcou, Y, Michael, T, Bashiardes, E, Cariolou, MA, Kakouri, E   +9 more
core   +6 more sources

A family history of breast cancer will not predict female early onset breast cancer in a population-based setting [PDF]

, 2008
: BACKGROUND: An increased risk of breast cancer for relatives of breast cancer patients has been demonstrated in many studies, and having a relative diagnosed with breast cancer at an early age is an indication for breast cancer screening.
de Bock, Geertruida H.; id_orcid, Seynaeve, C., Krol-Warmerdam Elly MM, Blom Jannet, de Bock, G.H., Cornelisse, C.J., Blom, Jannet, de Bock, GH, Brekelmans, C.T., Asperen, C.J. (Christi) van, Klijn, J.G., Jacobi, Catharina E., Houwelingen, J.C. van, van Asperen Christi J, Krol-Warmerdam, Elly M. M., Devilee, P, Brekelmans, C.T. (Cecile), Brekelmans Cecile TM, Klijn, Jan G. M., de Bock Geertruida H, Krol-Warmerdam, E.M., Krol-Warmerdam, EMM, van Asperen, C.J., Blom, J. (Jannet), Cornelisse Cees J, Jacobi, C.E., Tollenaar Rob AEM, Cornelisse, Cees J., Krol-Warmerdam, E.M.M. (Elly), Tollenaar, R.A., Seynaeve, C.M. (Caroline), Jacobi, CE, Tollenaar, R.A.E.M. (Rob), de Bock, Geertruida H., Blom, J., van Houwelingen, JC, Tollenaar, Rob A. E. M., van Asperen, Christi J., Brekelmans, CTM (Cecile), Bock, G.H. (Geertruida) de, van Asperen, CJ, Klijn Jan GM, van Houwelingen Johannes C, Devilee, Peter, Seynaeve Caroline, Brekelmans, Cecile T. M., Seynaeve, Caroline, Devilee Peter, Klijn, J.G.M. (Jan), Jacobi Catharina E, van Houwelingen, J.C., Klijn, Jan, Jacobi, C.E. (Catharina), Devilee, P. (Peter), Tollenaar, RAEM, Devilee, P., Cornelisse, C.J. (Cees), van Houwelingen, Johannes C., Blom, J, Cornelisse, CJ   +59 more
core   +2 more sources

Retrospective analysis of the treatment of BRCA1 and BRCA2 mutation carriers – the experience of a single-center tertiary institution

Nowotwory, 2023
INTRODUCTION: Breast cancer gene 1 and 2 (BRCA1/2) mutation carriers are at a higher risk of developing breast cancer. There are several established risk-reducing therapies.
Grzegorz J. Stępień, Thomas Wow, Agnieszka Kołacińska-Wow   +2 more
doaj   +1 more source

Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls. [PDF]

, 2009
If breast cancers arise independently in each breast the odds ratio (OR) for bilateral breast cancer for carriers of CHEK2 1100delC should be approximately 5.5, the square of the reported OR for a first primary (OR, 2.34).
Blomqvist, Carl,, Blomqvist, Carl, Peto, Julian, Muhammad U. Rashid, Johnson, Nichola, Fletcher, Olivia, Chekmariova, Elena V., Anna P. Sokolenko, Broeks, Annegien, Kristiina Aittomäki, Christina Justenhoven, Wasielewski, Marijke, Justenhoven, Christina, Alan Ashworth, Heli Nevanlinna, Ute Hamann, Annegien Broeks, Evgeny N. Imyanitov, Schmidt, Marjanka K., Dörk, Thilo, Michael Bremer, Isabel dos Santos Silva, Imyanitov, Evgeny N., Imyanitov, Evgeny N, Carl Blomqvist, Aittomäki, Kristiina, Rashid, Muhammad U., Kilpivaara, Outi, Laura J. Van't Veer, Hiltrud Brauch, Nichola Johnson, van't Veer, Laura J., Outi Kilpivaara, Nevanlinna, Heli, Ashworth, Alan, Hanne Meijers-Heijerboer, Sokolenko, Anna P, Rashid, Muhammad U, Chekmariova, Elena V, Dos Santos Silva, Isabel, Brauch, Hiltrud, Van't Veer, Laura J, Marijke Wasielewski, Sokolenko, Anna P., Thilo Dörk, Olivia Fletcher, Meijers-Heijerboer, Hanne, Schmidt, Marjanka K, Elena V. Chekmariova, Marjanka K. Schmidt, Julian Peto, Bremer, Michael, Hamann, Ute   +52 more
core   +1 more source

Evaluation of Patients with Synchronous Bilateral Breast Cancer

İstanbul Medical Journal, 2015
Objective: Breast cancer is the most common cancer in women. The incidence of bilateral breast cancer is 2%–11%. Synchronous bilateral breast cancer is uncommon (1%–2%). Bilateral breast cancer has worse prognosis than unilateral cancer.
Elif Eda Tiken, Meral Günaldı, Yıldız Okuturlar, Savaş Tuna   +3 more
doaj   +1 more source

Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy

대한영상의학회지, 2020
Herein, we report a case of synchronous bilateral triple negative invasive ductal breast carcinoma in a patient with discrepant pathologic response to neoadjuvant chemotherapy.
Gi Won Shin, Young Mi Park, Tae Hyun Kim, Anbok Lee, Ha Young Park, Hye Kyoung Yoon, Young Jin Heo, Jin Wook Baek, Yoo Jin Lee   +8 more
doaj   +1 more source

Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress [PDF]

, 2017
We, the Korean Breast Cancer Society (KBCS), present the facts and the trends of breast cancer in Korea in 2014. Data on the total number of newly diagnosed patients was obtained from the Korea Central Cancer Registry database, other data were collected ...
박병우
core   +1 more source

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

Hereditary Cancer in Clinical Practice, 2005
Purpose To compare the presentation of invasive breast cancer in BRCA1 and BRCA2 mutation carriers with and without prior bilateral oophorectomy. Patients and methods Women with a BRCA1 or BRCA2 mutation with the diagnosis of invasive breast cancer were ...
Metcalfe Kelly A, Foulkes William D, Lynch Henry T, Ghadirian Parviz, Tung Nadine, Olivotto Ivo A, Warner Ellen, Olopade Olufunmilayo, Eisen Andrea, Weber Barbara, McLennan Jane, Sun Ping, Narod Steven A   +12 more
doaj   +1 more source

Breast Implant-associated Anaplastic Large Cell Lymphoma after Breast Reconstruction for Breast Cancer

Plastic and Reconstructive Surgery, Global Open, 2023
A patient initially operated on for aesthetic breast augmentation had a round-textured silicone gel prosthesis, Poly Implants Prothèse, placed in a subglandular plane. The patient developed a bilateral capsular contracture, and 4 years later, underwent a
Felipe Mesa, MD, PhD, Julián Bernal Arrubla, MD, Luis Javier Gallón, MD, Gustavo Matute Turizo, MD, Diana Marcela Caicedo Ruiz, MD   +4 more
doaj   +1 more source